Overview Financials News + Filings IR Vault Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Auditor change
Appointed CFO
|
|
SCICLONE PHARMACEUTICALS INC (SCLN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/16/2017 |
4
| Blobel Friedhelm (President, CEO, Director) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Granted 150,000 shares
@ $0
Disposed/sold 387,299 shares
@ $11.18, valued at
$4.3M
Disposed/sold 142,610 options to buy
@ $5.13, valued at
$731.6k
Disposed/sold 200,000 options to buy
@ $6.22, valued at
$1.2M
Disposed/sold 200,000 options to buy
@ $4.53, valued at
$906k
Disposed/sold 200,000 options to buy
@ $4.52, valued at
$904k
Disposed/sold 42,725 options to buy
@ $8.83, valued at
$377.3k
Exercised 10,000 options to buy
@ $0
Disposed/sold 97,275 options to buy
@ $8.83, valued at
$858.9k
Exercised 50,000 options to buy
@ $0
Disposed/sold 11,243 options to buy
@ $9.12, valued at
$102.5k
|
|
| 10/16/2017 |
4
| SAXE JON S (Director) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Disposed/sold 135,000 shares
@ $11.18, valued at
$1.5M
Disposed/sold 30,000 options to buy
@ $1.75, valued at
$52.5k
Disposed/sold 30,000 options to buy
@ $2.23, valued at
$66.9k
Disposed/sold 30,000 options to buy
@ $3.01, valued at
$90.3k
Disposed/sold 30,000 options to buy
@ $6.04, valued at
$181.2k
Disposed/sold 30,000 options to buy
@ $6.78, valued at
$203.4k
Disposed/sold 30,000 options to buy
@ $5.13, valued at
$153.9k
Disposed/sold 30,000 options to buy
@ $5.1, valued at
$153k
Disposed/sold 30,000 options to buy
@ $9.15, valued at
$274.5k
Disposed/sold 30,000 options to buy
@ $10.9, valued at
$327k
|
|
| 10/16/2017 |
4
| Low Raymond Anthony (VP, Finance & Controller) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Disposed/sold 37,748 shares
@ $11.18, valued at
$422k
Disposed/sold 50,000 options to buy
@ $4.75, valued at
$237.5k
Disposed/sold 31,012 options to buy
@ $8.83, valued at
$273.8k
Exercised 2,500 options to buy
@ $0
Disposed/sold 3,988 options to buy
@ $8.83, valued at
$35.2k
Disposed/sold 15,923 options to buy
@ $9.12, valued at
$145.2k
Disposed/sold 19,077 options to buy
@ $9.12, valued at
$174k
Exercised 3,750 options to buy
@ $0
Exercised 5,000 options to buy
@ $0
Disposed/sold 10,574 options to buy
@ $9.65, valued at
$102k
Disposed/sold 24,426 options to buy
@ $9.65, valued at
$235.7k
|
|
| 10/16/2017 |
4
| Zhao Hong (CEO, China Operations) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Granted 75,000 shares
@ $0
Disposed/sold 127,000 shares
@ $11.18, valued at
$1.4M
Disposed/sold 90,000 options to buy
@ $4.52, valued at
$406.8k
Disposed/sold 84,000 options to buy
@ $8.83, valued at
$741.7k
Exercised 6,000 options to buy
@ $0
Exercised 25,000 options to buy
@ $0
Disposed/sold 84,000 options to buy
@ $9.12, valued at
$766.1k
Exercised 9,000 options to buy
@ $0
Exercised 12,000 options to buy
@ $0
Disposed/sold 84,000 options to buy
@ $9.65, valued at
$810.6k
|
|
| 10/16/2017 |
4
| Li Simon (Director) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Disposed/sold 50,000 options to buy
@ $4.85, valued at
$242.5k
Disposed/sold 12,500 options to buy
@ $5.13, valued at
$64.1k
Disposed/sold 30,000 options to buy
@ $5.1, valued at
$153k
Disposed/sold 30,000 options to buy
@ $9.15, valued at
$274.5k
Disposed/sold 30,000 options to buy
@ $10.9, valued at
$327k
|
|
| 10/16/2017 |
4
| CHANG NANCY T (Director) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Disposed/sold 70,000 shares
@ $11.18, valued at
$782.6k
Disposed/sold 30,000 options to buy
@ $9.15, valued at
$274.5k
Disposed/sold 30,000 options to buy
@ $10.9, valued at
$327k
|
|
| 10/16/2017 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Disposed/sold 50,000 options to buy
@ $1.24, valued at
$62k
Disposed/sold 5,000 options to buy
@ $2.23, valued at
$11.2k
Disposed/sold 30,000 options to buy
@ $3.01, valued at
$90.3k
Disposed/sold 30,000 options to buy
@ $6.04, valued at
$181.2k
Disposed/sold 30,000 options to buy
@ $6.78, valued at
$203.4k
Disposed/sold 30,000 options to buy
@ $5.13, valued at
$153.9k
Disposed/sold 30,000 options to buy
@ $5.1, valued at
$153k
Disposed/sold 30,000 options to buy
@ $9.15, valued at
$274.5k
Disposed/sold 30,000 options to buy
@ $10.9, valued at
$327k
|
|
| 10/16/2017 |
4
| Chern Carey (General Counsel) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 11,274 shares
@ $11.18, valued at
$126k
Disposed/sold 20,708 shares
@ $11.18, valued at
$231.5k
Disposed/sold 38,644 options to buy
@ $10.35, valued at
$400k
Disposed/sold 41,356 options to buy
@ $10.35, valued at
$428k
Exercised 30,000 options to buy
@ $0 |
|
| 10/16/2017 |
4
| Xie Lan (VP Finance, China CFO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Disposed/sold 8,000 shares
@ $11.18, valued at
$89.4k
Disposed/sold 2,500 options to buy
@ $4.53, valued at
$11.3k
Disposed/sold 16,667 options to buy
@ $4.52, valued at
$75.3k
Disposed/sold 18,667 options to buy
@ $8.83, valued at
$164.8k
Exercised 2,000 options to buy
@ $0
Disposed/sold 28,000 options to buy
@ $9.12, valued at
$255.4k
Exercised 3,000 options to buy
@ $0
Disposed/sold 21,000 options to buy
@ $9.65, valued at
$202.7k
|
|
| 10/16/2017 |
4
| Hawkins Richard J (Director) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Disposed/sold 24,363 shares
@ $11.18, valued at
$272.4k
Disposed/sold 30,000 options to buy
@ $6.04, valued at
$181.2k
Disposed/sold 30,000 options to buy
@ $6.78, valued at
$203.4k
Disposed/sold 30,000 options to buy
@ $5.13, valued at
$153.9k
Disposed/sold 30,000 options to buy
@ $5.1, valued at
$153k
Disposed/sold 30,000 options to buy
@ $9.15, valued at
$274.5k
Disposed/sold 30,000 options to buy
@ $10.9, valued at
$327k
|
|
| 10/16/2017 |
4
| Cheung Wilson Wai-Shun (CFO & Senior VP, Finance) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Granted 75,000 shares
@ $0
Disposed/sold 144,158 shares
@ $11.18, valued at
$1.6M
Disposed/sold 9,375 options to buy
@ $5.97, valued at
$56k
Disposed/sold 24,792 options to buy
@ $4.52, valued at
$112.1k
Disposed/sold 39,225 options to buy
@ $8.83, valued at
$346.4k
Exercised 6,000 options to buy
@ $0
Disposed/sold 44,775 options to buy
@ $8.83, valued at
$395.4k
Exercised 25,000 options to buy
@ $0
Disposed/sold 11,131 options to buy
@ $9.12, valued at
$101.5k
Disposed/sold 72,869 options to buy
@ $9.12, valued at
$664.6k
Exercised 9,000 options to buy
@ $0 |
|
| 08/16/2017 |
4
| Zhao Hong (CEO, China Operations) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Sold 30,000 shares
@ $11, valued at
$330k
Exercised 30,000 options to buy
@ $0 |
|
| 08/16/2017 |
4
| Xie Lan (VP Finance, China CFO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Sold 10,000 shares
@ $11, valued at
$110k
Exercised 10,000 options to buy
@ $0 |
|
| 08/16/2017 |
4
| Blobel Friedhelm (President & CEO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 20,872 shares
@ $11.05, valued at
$230.6k
Exercised 40,000 options to buy
@ $0 |
|
| 08/16/2017 |
4
| Cheung Wilson Wai-Shun (CFO & Senior VP, Finance) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 14,714 shares
@ $11.05, valued at
$162.6k
Exercised 30,000 options to buy
@ $0 |
|
| 08/16/2017 |
4
| Low Raymond Anthony (VP, Finance & Controller) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Exercised 10,000 options to buy
@ $0 |
|
| 07/03/2017 |
4
| Blobel Friedhelm (President & CEO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Sold 27,654 shares
@ $11, valued at
$304.2k
Sold 7,390 shares
@ $11, valued at
$81.3k
Exercised 27,654 options to buy
@ $3.55, valued at
$98.2k
Exercised 7,390 options to buy
@ $5.13, valued at
$37.9k
|
|
| 06/22/2017 |
4
| Blobel Friedhelm (President & CEO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Sold 30,000 shares
@ $10.9033, valued at
$327.1k
Sold 40,000 shares
@ $10.9132, valued at
$436.5k
Exercised 30,000 options to buy
@ $3.55, valued at
$106.5k
Exercised 40,000 options to buy
@ $3.55, valued at
$142k
|
|
| 06/14/2017 |
4
| Blobel Friedhelm (President & CEO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 26,090 shares
@ $10.75, valued at
$280.5k
Exercised 5,000 options to buy
@ $0
Exercised 50,000 options to buy
@ $0 |
|
| 06/14/2017 |
4
| Cheung Wilson Wai-Shun (CFO & Senior VP, Finance) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Sold 12,500 shares
@ $10.75, valued at
$134.4k
Sold 3,000 shares
@ $10.75, valued at
$32.3k
Sold 25,000 shares
@ $10.75, valued at
$268.8k
Exercised 12,500 options to buy
@ $0
Exercised 3,000 options to buy
@ $0
Exercised 25,000 options to buy
@ $0 |
|
| 06/14/2017 |
4
| Low Raymond Anthony (VP, Finance & Controller) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Exercised 1,250 options to buy
@ $0 |
|
| 06/14/2017 |
4
| Xie Lan (VP Finance, China CFO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Sold 1,000 shares
@ $10.75, valued at
$10.8k
Exercised 1,000 options to buy
@ $0 |
|
| 06/14/2017 |
4
| Zhao Hong (CEO, China Operations) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Sold 3,000 shares
@ $10.75, valued at
$32.3k
Sold 12,500 shares
@ $10.75, valued at
$134.4k
Sold 25,000 shares
@ $10.75, valued at
$268.8k
Exercised 12,500 options to buy
@ $0
Exercised 25,000 options to buy
@ $0
Exercised 3,000 options to buy
@ $0 |
|
| 06/09/2017 |
4
| Blobel Friedhelm (President & CEO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Sold 19,700 shares
@ $10.0266, valued at
$197.5k
Sold 19,956 shares
@ $11.0046, valued at
$219.6k
Exercised 19,700 options to buy
@ $3.55, valued at
$69.9k
Exercised 19,956 options to buy
@ $3.55, valued at
$70.8k
|
|
| 06/09/2017 |
4
| Hawkins Richard J (Director) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $10.9, valued at
$327k
|
|
| 06/09/2017 |
4
| CHANG NANCY T (Director) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $10.9, valued at
$327k
|
|
| 06/09/2017 |
4
| LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $10.9, valued at
$327k
|
|
| 06/09/2017 |
4
| Li Simon (Director) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $10.9, valued at
$327k
|
|
| 06/09/2017 |
4
| SAXE JON S (Director) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $10.9, valued at
$327k
|
|
| 06/06/2017 |
4
| Blobel Friedhelm (President & CEO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Sold 4,800 shares
@ $10, valued at
$48k
Sold 5,500 shares
@ $10, valued at
$55k
Exercised 4,800 options to buy
@ $3.55, valued at
$17k
Exercised 5,500 options to buy
@ $3.55, valued at
$19.5k
|
|
| 05/25/2017 |
4
| Blobel Friedhelm (President & CEO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Sold 15,166 shares
@ $9.3073, valued at
$141.2k
Sold 6,298 shares
@ $9.3641, valued at
$59k
Exercised 15,166 options to buy
@ $3.55, valued at
$53.8k
Exercised 6,298 options to buy
@ $3.55, valued at
$22.4k
|
|
| 05/23/2017 |
4
| Blobel Friedhelm (President & CEO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC|
Txns:
| Sold 18,536 shares
@ $9.4425, valued at
$175k
Exercised 18,536 options to buy
@ $3.55, valued at
$65.8k
|
|
| 05/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/03/2017 |
4
| Blobel Friedhelm (President & CEO) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC |
|
|
|